| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 12/26/2012 | CN102836215A Application of Chinese crossostepium leaf capsules in preparation of A875 cell multiplication inhibiting drugs |
| 12/26/2012 | CN102836198A Cancer-restraining medicine and preparation method thereof |
| 12/26/2012 | CN102836196A Maca extract and preparation method thereof |
| 12/26/2012 | CN102836194A Extraction method of affine cudweed total flavonoids |
| 12/26/2012 | CN102836193A Lucid ganoderma composite spore powder and preparation method thereof |
| 12/26/2012 | CN102836191A Green lucid ganoderma traditional Chinese drug composition and preparation method thereof |
| 12/26/2012 | CN102836184A Ciliate desert-grass extract with action of resisting prostatic cancers and preparation method thereof |
| 12/26/2012 | CN102836182A Extraction process of Ganoderma lucidum acidic components |
| 12/26/2012 | CN102836181A Antradiacomphora oral liquid and preparation method thereof |
| 12/26/2012 | CN102836179A Method for extracting polyphenol material in plants |
| 12/26/2012 | CN102836174A Cancer treatment novel technology cellular molecule nuclear fission mode-regulation technology |
| 12/26/2012 | CN102836169A Application of surfactant chemical ablation agent and preparation method in medicines for treating tumors |
| 12/26/2012 | CN102836160A Combined medicament for treating cancers |
| 12/26/2012 | CN102836158A Lipid body loaded with chloroquine drugs and paclitaxel drugs together and preparation method of same |
| 12/26/2012 | CN102836151A Application of Brevilin A when serving as JAK-STATs signal target inhibitor |
| 12/26/2012 | CN102836150A Drug combination containing borneol |
| 12/26/2012 | CN102836149A Composition used for inhibiting tumor cell proliferation, and application thereof |
| 12/26/2012 | CN102836148A Medicine compound for curing cervical diseases |
| 12/26/2012 | CN102836147A Paclitaxel-entrapped biodegradable nanocomposite and preparation method thereof |
| 12/26/2012 | CN102836140A Arctigenin micro-emulsion enteric soft capsule preparation |
| 12/26/2012 | CN102836127A Docetaxel transferrin acceptor-targeted liposome preparation |
| 12/26/2012 | CN102835240A Cultivation method of selenium-enriched Codonopsis lanceolata, as well as extraction method and application of selenium-containing polysaccharide of selenium-enriched Codonopsis lanceolata |
| 12/26/2012 | CN102397545B Nano-photosensitizer medicine delivery system for photodynamic therapy and preparation method for nano-photosensitizer medicine delivery system |
| 12/26/2012 | CN102391353B Walsuralactam A and preparation method and application in medicament thereof |
| 12/26/2012 | CN102379901B Toad-cortex ultra-micro powder soft capsule and preparation method thereof |
| 12/26/2012 | CN102379840B Preparation and application of micromolecular hydrogel with electroresponsive characteristic |
| 12/26/2012 | CN102302663B Chinese medicine for treating primary carcinoma of liver |
| 12/26/2012 | CN102204921B Application of tetracycline derivative in preparing sensitizing drug for radiotherapy |
| 12/26/2012 | CN102178935B Preparation for resisting radiation, enhancing body immunity and preventing and treating tumors |
| 12/26/2012 | CN102161982B Monoclonal antibodies (McAb) against human CXCR3 molecules and application thereof |
| 12/26/2012 | CN102138921B Application of phthalimide derivatives in preparation of anti-angiogenesis medicaments |
| 12/26/2012 | CN102080086B Human miR-133a antisense nucleic acid and application thereof |
| 12/26/2012 | CN102078302B Method for preparing berbamine chitosan-agar nano particles |
| 12/26/2012 | CN102028952B Galactan sulfate 5-fluorouracil compound and preparation and application thereof |
| 12/26/2012 | CN101939020B Application of degarelix in preparing medicine of metastatic stage prostate cancer |
| 12/26/2012 | CN101932564B Hydroxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors |
| 12/26/2012 | CN101889982B Novel long-circulating liposome composition and preparation method thereof |
| 12/26/2012 | CN101863985B Recombinant human fusion Tat cytoglobulin and application thereof in treating liver cancer |
| 12/26/2012 | CN101676267B N-4-(1-cyan cyclopentyl) phenyl-2-(4-picolyl) amidogen-3-pyridinecarboxamide salt |
| 12/26/2012 | CN101648923B Hydroxamic acid compound used as histone deacetylase inhibitor and application thereof |
| 12/26/2012 | CN101596225B Anti-tumour traditional Chinese medicine preparation containing glossy ganoderma spore oil and preparation method thereof |
| 12/26/2012 | CN101568550B Peptide vaccines for cancers expressing mphosph1 or depdc1 polypeptides |
| 12/26/2012 | CN101524377B Composite of wall-breaking lucidum spore powder and cyclodextrin and preparation method thereof |
| 12/26/2012 | CN101513526B Application of combined vaccine in treating tumors |
| 12/26/2012 | CN101495630B Gene involved in immortalization of human cancer cell and use thereof |
| 12/26/2012 | CN101460520B Hepatocyte growth factor (hgf) binding proteins |
| 12/26/2012 | CN101313931B Application of Heichou extract in preparing antineoplastic medicament |
| 12/26/2012 | CN101313926B Transcription regulating and controlling article composition |
| 12/26/2012 | CN101304978B Quinazoline derivatives as a multiplex inhibitor, pharmaceutical composition and uses thereof |
| 12/26/2012 | CN101302208B Compound inhibiting glutathion S-transferase activity, preparation and use thereof |
| 12/26/2012 | CN101210051B Anti-VEGF antibodies |
| 12/26/2012 | CN101139392B KDR peptides and vaccines containing the same |
| 12/26/2012 | CN101128425B Dimeric IAP inhibitors |
| 12/25/2012 | US8338595 Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |
| 12/25/2012 | US8338594 Pyrrolotriazine derivatives useful for treating cancer through inhibition of aurora kinase |
| 12/25/2012 | US8338575 IL-7 fusion proteins |
| 12/25/2012 | US8338475 Anti-proliferative pharmaceutical composition |
| 12/25/2012 | US8338456 Cut-point in PTEN protein expression that accurately identifies tumors and is predictive of drug response to a pan-ErbB inhibitor |
| 12/25/2012 | US8338431 Phosphodiesterase inhibitors |
| 12/25/2012 | US8338422 Indolin-2-ones and aza-indolin-2-ones |
| 12/25/2012 | US8338416 Indole derivatives as inhibitors of histone deacetylase |
| 12/25/2012 | US8338414 Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient |
| 12/25/2012 | US8338401 Coumarin-amide derivatives and its preparation, said drug composition and its use |
| 12/25/2012 | US8338384 Method for treating ocular neovascularization |
| 12/25/2012 | US8338367 Fused heteroaryl diamide compounds useful as MMP-13 inhibitors |
| 12/25/2012 | US8338365 Inhibiting integrin receptor binding with non-native monomeric disintegrin or monomeric disintegrin domains |
| 12/25/2012 | US8338168 Chimeric glycoproteins and pseudotyped lentiviral vectors |
| 12/25/2012 | US8337886 Pellet formulation for the treatment of the intestinal tract |
| 12/25/2012 | US8337829 Conditioned medium and proliferated cell lines produced therefrom |
| 12/20/2012 | WO2012174549A2 Blockade of eosinophil production by toll-like receptors |
| 12/20/2012 | WO2012174446A1 Frizzled 2 as a target for therapeutic antibodies in the treatment of cancer |
| 12/20/2012 | WO2012174436A1 Nuclear receptor modulators and their use for the treatment and prevention of cancer |
| 12/20/2012 | WO2012174423A1 Stabilized polypeptides as regulators of rab gtpase function |
| 12/20/2012 | WO2012174394A1 Methods of enhancing the response to radiation in tumor therapy using anti-dll4 antibodies |
| 12/20/2012 | WO2012174327A1 Combination therapies for treating hematologic malignancies using pyridopyrimidinone inhibitors of pi3k/mtor with bendamustine and/or rituximab |
| 12/20/2012 | WO2012174253A1 Methods for aloe processing |
| 12/20/2012 | WO2012174203A2 Methods and kits for the detection and treatment of recurring prostate cancer |
| 12/20/2012 | WO2012174160A1 Tem8 antibodies, conjugates thereof, and their use |
| 12/20/2012 | WO2012174095A1 3-desoxy-2-methylene-19-nor-vitamin d analogs and their uses |
| 12/20/2012 | WO2012174082A1 Modified release of 4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-n-5-(4-methyl-1h-imidazol-1-yl)-3-(trifluoromethyl)phenyl] benzamide solubilized using organic acids |
| 12/20/2012 | WO2012174028A2 Peptide compositions and methods for treating lung injury, asthma, anaphylaxis, angioedema, systemic vascular permeability syndromes, and nasal congestion |
| 12/20/2012 | WO2012173987A2 Methods of treatment using a bcat1 inhibitor |
| 12/20/2012 | WO2012173682A2 Compounds and methods for the treatment of isocitrate dehydrognase related diseases |
| 12/20/2012 | WO2012173217A1 Crystal of pyrroloquinolinequinone disodium salt, and method for producing same |
| 12/20/2012 | WO2012173163A1 Crushed cells and composition thereof |
| 12/20/2012 | WO2012172555A1 Combination therapy to prevent dcis formation and progression to breast cancer |
| 12/20/2012 | WO2012172069A1 Glioblastoma inhibiting compounds and their use |
| 12/20/2012 | WO2012171654A1 Oncolytic virotherapy for the therapy of sarcoma |
| 12/20/2012 | WO2012171506A1 Compounds, their pharmaceutical compositions and their uses as idh1 mutants inhibitors for treating cancers |
| 12/20/2012 | WO2012171488A1 Coumarin derivative, pharmaceutical composition and use thereof |
| 12/20/2012 | WO2012171487A1 Aryloxy quinolines derivatives and the treating use thereof |
| 12/20/2012 | WO2012171337A1 Therapeutically active compositions and their methods of use |
| 12/20/2012 | WO2012171231A1 Uses of protein acrosin and the preparation method thereof |
| 12/20/2012 | WO2012171114A1 Synthetic epigallocatechin gallate (egcg) analogs |
| 12/20/2012 | WO2012144726A3 Tumor antigen proteins or genes of polo-like kinase 1 |
| 12/20/2012 | WO2012143624A3 Acadesine derivatives, products and compositions including same, therapeutic uses thereof, and methods for synthesizing same |
| 12/20/2012 | WO2012131487A3 Compositions and methods for the treatment of cancer |
| 12/20/2012 | WO2012115437A3 Pharmaceutical composition for cancer treatment or metastasis inhibition containing expression or activation inhibitors of map7d2 protein, novel cancer therapeutic target |
| 12/20/2012 | WO2012108746A3 Composition and cosmetic composition for treating brain cancer comprising rubia cordifolia root extract |
| 12/20/2012 | WO2012102527A3 Novel use of regulatory t cell-specific surface protein lrig-1 |